Hosted on MSN2d
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsWellness company Medifast (NYSE:MED) in Q4 CY2024, but sales fell by 37.7% year on year to $119 million. On the other hand, ...
Janney Montgomery Scott LLC lessened its stake in Medifast, Inc. (NYSE:MED – Free Report) by 9.6% during the fourth quarter, ...
Wellness company Medifast (NYSE:MED) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 37.7% year on year to $119 million. On the other hand, next quarter’s revenue ...
Hosted on MSN1mon
Medifast stock hits 52-week low at $15.09 amid sharp declineI n a challenging year for Medifast (NYSE:MED) Inc., the company's stock has plummeted to a 52-week low, touching down at $15.09. This significant drop reflects a stark 72.61% decrease from the ...
Medifast, Inc. MED has introduced a high-protein product line, OPTAVIA ASCEND, designed to support individuals using GLP-1 medications and those seeking help to maintain weight loss. The new line ...
Shares of Medifast stock opened at $16.19 on Friday. Medifast has a 52-week low of $14.76 and a 52-week high of $52.96. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback